Graduated from Peking University Health Science Center in 2011 with a Doctor of Surgery degree. Promoted to Attending Physician in 2015 and Associate Chief Physician in 2021. Currently serves as Secretary of the Soft Tissue and Retroperitoneal Tumor Center at Peking University Cancer Hospital, and Party Branch Secretary of the Second Department of Hepatobiliary Surgery. Specializes in the surgical treatment of hepatobiliary and pancreatic tumors, retroperitoneal tumors, and gastrointestinal stromal tumors. In 2024, was publicly dispatched as a visiting scholar to Heidelberg University in Germany for one year, where he studied hepatobiliary and pancreatic minimally invasive surgery and soft tissue sarcoma surgery at the University Hospital Mannheim, Heidelberg University. Current social positions include: Secretary-General of the Soft Tissue Oncology Branch of the China International Exchange and Promotive Association for Medical and Health Care, Member of the Expert Working Group on Retroperitoneal and Soft Tissue Tumors of the Chinese College of Surgeons, and Member of the Youth Committee of the Hepatobiliary and Pancreatic Surgery Professional Committee of the Cross-Straits Medicine Exchange Association. In recent years, has published nearly 20 papers as first author or corresponding author in domestic and international journals, and has led one sub-project of the National Natural Science Foundation of China's major program. Published Papers SCI papers published as first author and corresponding author in the past five years are as follows: 1. Li CP, Wang Z, Liu BN, Lv A, Liu DN, Wu JH, Qiu H, Hao CY. Pancreaticoduodenectomy for Retroperitoneal Sarcomas: A Mono-Institutional Experience in China. Front Oncol. 2020 Sep 23;10:548789. doi: 10.3389/fonc.2020.548789. PMID: 33072576; PMCID: PMC7538706. 2. Li CP, Liu DN, Zhou NN, Tian XY, Wang Z, Liu BN, Hao CY. Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on 18F-FDG PET/CT in Patients with Retroperitoneal Liposarcoma. Contrast Media Mol Imaging. 2021 Jan 6;2021:7191363. doi: 10.1155/2021/7191363. PMID: 33505228; PMCID: PMC7806371. 3. Li CP, Liu BN, Wu JH, Hao CY. Contralateral internal iliac artery transposition for retroperitoneal sarcoma involving common iliac artery. Updates Surg. 2022 Jun;74(3):1157-1163. doi: 10.1007/s13304-020-00843-1. Epub 2020 Jun 29. PMID: 32602011. 4. Liu DN, Li CP, Li HW, Wang HY, Tian XY, Hao CY. Volume-based 18F-FDG PET/CT predicts prognosis and outcome of active surveillance for intra-abdominal desmoid tumor. Abdom Radiol (NY). 2024 Mar;49(3):958-963. doi: 10.1007/s00261-023-04145-z. Epub 2024 Jan 21. 5. Jia WW, Wu JH, Zhang HT, Wu Y, Liu DN, Wang Z, Wang XP, Li CP, Hao CY. Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma. Ther Adv Med Oncol. 2024 Sep 10;16:17588359241276968. doi: 10.1177/17588359241276968. 6. Jia WW, Wu JH, Yang C, Liu DN, Wang XP, Sun RZ, Li CP, Hao CY. An additional gastrojejunostomy may reduce the incidence of moderate and severe delayed gastric emptying after distal segmental duodenectomy for gastrointestinal stromal tumors. World J Surg Oncol. 2024 Nov 14;22(1):303. doi: 10.1186/s12957-024-03585-1. 7. Li CP, Jakob J, Menge F, Reißfelder C, Hohenberger P, Yang C. Comparing ChatGPT-3.5 and ChatGPT-4’s Alignments with the German evidence-based S3 Guideline for Adult Soft Tissue Sarcoma. iScience. 2024:111493. doi:10.1016/j.isci.2024.111493. iScience. 8. Li CP, Jia WW, Chu Y, Menge F, Speer T, Reißfelder C, Hohenberger P, Jakob J, Yang C. Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries using GPT-4o Enhanced with German Evidence-Based Guidelines. Oncol Res Treat. 2025 Feb 28:1-18. doi: 10.1159/000544978. Epub ahead of print.